Location: Boston, MA
CIK: 0001595855 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value: $438M (98.2% shares, 1.8% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HROW | HARROW HEALTH INC | 3,990,000 | $83.35M | 19.0% | $6.33 | +136.1% | COM | 415858109 |
| TGTX | TG THERAPEUTICS INC | 2,280,000 | $40.56M | 9.3% | $13.67 | +16.8% | COM | 88322Q108 |
| OCUL | OCULAR THERAPEUTIX INC | 5,307,500 | $36.3M | 8.3% | $5.10 | +21.1% | COM | 67576A100 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 515,000 | $21.15M | 4.8% | $12.73 | +213.5% | COM | 76243J105 |
| KROS | KEROS THERAPEUTICS INC | 367,500 | $16.79M | 3.8% | $47.67 | +12.7% | COM | 492327101 |
| ARVN | ARVINAS INC | 555,000 | $14.77M | 3.4% | $29.24 | +9.0% | COM | 04335A105 |
| IMNM | IMMUNOME INC | 1,102,500 | $13.34M | 3.0% | $15.64 | 0.0% | COM | 45257U108 |
| CYTK | CYTOKINETICS INC | 198,500 | $10.75M | 2.5% | $60.36 | 0.0% | COM NEW | 23282W605 |
| CDXS | CODEXIS INC | 3,455,000 | $10.71M | 2.4% | $2.59 | +24.2% | COM | 192005106 |
| EWTX | EDGEWISE THERAPEUTICS INC | 580,000 | $10.45M | 2.4% | $10.13 | +72.2% | COM | 28036F105 |
| CPRX | CATALYST PHARMACEUTICALS INC | 640,000 | $9.914M | 2.3% | $13.39 | +16.3% | COM | 14888U101 |
| — | CARGO THERAPEUTICS INC | 555,700 | $9.125M | 2.1% | $16.42 | — | COM | 14179K101 |
| JSPR | JASPER THERAPEUTICS INC | 392,000 | $8.898M | 2.0% | $17.76 | +35.0% | COM NEW | 471871202 |
| NRIX | NURIX THERAPEUTICS INC | 418,928 | $8.743M | 2.0% | $12.50 | +24.6% | COM | 67080M103 |
| TRVI | TREVI THERAPEUTICS INC | 2,645,000 | $7.882M | 1.8% | $2.06 | +35.0% | COM | 89532M101 |
| ETON | ETON PHARMACEUTICALS INC | 2,395,000 | $7.88M | 1.8% | $5.82 | -39.8% | COM | 29772L108 |
| — | APPLIED THERAPEUTICS INC' | 1,680,000 | $7.846M | 1.8% | $4.24 | — | COM | 03828A101 |
| FDMT | 4D MOLECULAR THERAPEUTICS INC | 345,750 | $7.257M | 1.7% | $20.37 | +23.2% | COM | 35104E100 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 897,000 | $7.194M | 1.6% | $6.29 | +70.4% | COM | 462260100 |
| — | ACELYRIN INC | 1,580,000 | $6.968M | 1.6% | $20.90 | — | COM | 00445A100 |
| URGN | UROGEN PHARMA LTD | 412,000 | $6.913M | 1.6% | $10.29 | +38.3% | COM | M96088105 |
| PCVX | VAXCYTE INC | 85,000 | $6.418M | 1.5% | $38.73 | +75.7% | COM | 92243G108 |
| — | BIODESIX INC | 4,020,000 | $6.151M | 1.4% | $2.17 | — | COM | 09075X108 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 315,000 | $6.051M | 1.4% | $10.93 | +83.6% | ORDINARY SHARES | N62509109 |
| XOMA | XOMA CORP DEL | 250,000 | $5.923M | 1.4% | $11.26 | +122.0% | COM NEW | 98419J206 |
| TARA | PROTARA THERAPEUTICS INC | 2,304,262 | $5.3M | 1.2% | $29.10 | -90.0% | COM STK | 74365U107 |
| NTLA | INTELLIA THERAPEUTICS INC | 218,000 | $4.879M | 1.1% | $28.15 | -15.4% | COM | 45826J105 |
| NUVL | NUVALENT INC | 59,300 | $4.498M | 1.0% | $71.13 | 0.0% | COM | 670703107 |
| SYRS | SYROS PHARMACEUTICALS INC | 865,443 | $4.466M | 1.0% | $5.32 | -1.2% | COM NEW | 87184Q206 |
| — | GOSSAMER BIO INC | 8,000,000 | $3.958M | 0.9% | $0.39 | — | NOTE 5.000% 6/0 | 38341PAA0 |
| LQDA | LIQUIDIA CORPORATION | 325,000 | $3.9M | 0.9% | $5.52 | +140.4% | COM NEW | 53635D202 |
| — | KARYOPHARM THERAPEUTICS INC | 6,000,000 | $3.747M | 0.9% | $0.62 | — | NOTE 3.000%10/1 | 48576UAA4 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 105,000 | $3.638M | 0.8% | $17.50 | +67.4% | COM | 74366E102 |
| GOSS | GOSSAMER BIO INC | 3,910,000 | $3.523M | 0.8% | $1.04 | -28.2% | COM | 38341P102 |
| LXRX | LEXICON PHARMACEUTICALS INC | 1,875,000 | $3.15M | 0.7% | $1.79 | 0.0% | COM NEW | 528872302 |
| SVRA | SAVARA INC | 714,960 | $2.881M | 0.7% | $4.83 | -7.9% | COM | 805111101 |
| — | ALLAKOS INC | 2,780,000 | $2.78M | 0.6% | $1.23 | — | COM | 01671P100 |
| VTYX | VENTYX BIOSCIENCES INC | 1,190,000 | $2.749M | 0.6% | $8.94 | -53.5% | COM | 92332V107 |
| VSTM | VERASTEM INC | 915,000 | $2.727M | 0.6% | $8.26 | -0.2% | COM NEW | 92337C203 |
| — | REGULUS THERAPEUTICS INC | 1,475,000 | $2.633M | 0.6% | $1.91 | — | COM | 75915K309 |
| — | LYELL IMMUNOPHARMA INC | 1,670,000 | $2.421M | 0.6% | $2.23 | — | COM | 55083R104 |
| RLMD | RELMADA THERAPEUTICS INC | 600,000 | $1.8M | 0.4% | $2.96 | +22.2% | COM | 75955J402 |
| FULC | FULCRUM THERAPEUTICS INC | 285,000 | $1.767M | 0.4% | $6.14 | +23.3% | COM | 359616109 |
| — | KARYOPHARM THERAPEUTICS INC | 1,425,000 | $1.236M | 0.3% | $0.87 | — | COM | 48576U106 |
| IBIO | IBIO INC | 375,000 | $791K | 0.2% | $1.26 | +71.0% | COM NEW | 451033708 |
| PMVP | PMV PHARMACEUTICALS INC | 475,000 | $770K | 0.2% | $1.87 | -3.4% | COM | 69353Y103 |
| — | AEROVATE THERAPEUTICS INC | 440,000 | $730K | 0.2% | $1.66 | — | COM | 008064107 |
| DSGN | DESIGN THERAPEUTICS INC | 205,000 | $687K | 0.2% | $3.22 | +21.0% | COM | 25056L103 |
| ABCL | ABCELLERA BIOLOGICS INC | 200,000 | $592K | 0.1% | $3.78 | 0.0% | COM | 00288U106 |
| — | ALIGOS THERAPEUTICS INC | 1,260,000 | $441K | 0.1% | $0.73 | — | COM | 01626L105 |
| — | RENEO PHARMACEUTICALS INC | 165,000 | $249K | 0.1% | $1.51 | — | COM | 75974E103 |